Updated Jul 16, 2026
Nachman Shlomo has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Nachman Shlomo is identified in SEC filings as a director of AtriCure, Inc. as of May 20, 2026. Publicly available information from widely accessible sources provides limited biographical details beyond his board role, and there is no conclusive evidence in the provided context of his broader professional history. Based on the SEC filing context, he serves on the board of AtriCure, and this constitutes his primary current public-facing position in this context.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | ATRC | AtriCure, Inc. | A — Grant or award | 6.1K | $0.00 |
Nachman Shlomo is identified in SEC filings as a director of AtriCure, Inc. as of May 20, 2026. Publicly available information from widely accessible sources provides limited biographical details beyond his board role, and there is no conclusive evidence in the provided context of his broader professional history. Based on the SEC filing context, he serves on the board of AtriC…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Nachman Shlomo profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.